CA3105039A1 - Stabilite de la vitamine d dans .beta.-hydroxy .beta.-methylbutyrate (hmb) - Google Patents
Stabilite de la vitamine d dans .beta.-hydroxy .beta.-methylbutyrate (hmb) Download PDFInfo
- Publication number
- CA3105039A1 CA3105039A1 CA3105039A CA3105039A CA3105039A1 CA 3105039 A1 CA3105039 A1 CA 3105039A1 CA 3105039 A CA3105039 A CA 3105039A CA 3105039 A CA3105039 A CA 3105039A CA 3105039 A1 CA3105039 A1 CA 3105039A1
- Authority
- CA
- Canada
- Prior art keywords
- vitamin
- hmb
- hmbfa
- formulation
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une composition comprenant une formulation acide contenant du ß-hydroxy-ß-méthylbutyrate (HMB), de préférence sous la forme d'acide libre, de la vitamine D et un excipient de stabilisation, la vitamine D étant stabilisée contre la dégradation.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2019/038948 WO2020263229A1 (fr) | 2019-06-25 | 2019-06-25 | STABILITÉ DE LA VITAMINE D DANS DU β-HYDROXY-β-MÉTHYLBUTYRATE (HMB) |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3105039A1 true CA3105039A1 (fr) | 2020-12-30 |
Family
ID=74060572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3105039A Pending CA3105039A1 (fr) | 2019-06-25 | 2019-06-25 | Stabilite de la vitamine d dans .beta.-hydroxy .beta.-methylbutyrate (hmb) |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2022545299A (fr) |
KR (1) | KR20220050082A (fr) |
CN (1) | CN113056206A (fr) |
AU (1) | AU2019453386A1 (fr) |
CA (1) | CA3105039A1 (fr) |
SG (1) | SG11202012984YA (fr) |
WO (1) | WO2020263229A1 (fr) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6849613B2 (en) * | 2001-08-29 | 2005-02-01 | Kedar N. Prasad | Multiple antioxidant micronutrients |
US20060019933A1 (en) * | 2004-07-22 | 2006-01-26 | David Boardman | Process for preparing stabilized vitamin D |
US20100178369A1 (en) * | 2009-01-15 | 2010-07-15 | Nicole Lee Arledge | Antioxidant-stabilized concentrated fish oil |
SG192692A1 (en) * | 2011-02-07 | 2013-09-30 | Abbott Lab | Nutritional products comprising beta-hydroxy-beta-methylbutyrate |
CN102512655B (zh) * | 2011-11-30 | 2013-10-30 | 北京康比特体育科技股份有限公司 | 左旋肉碱组合物和制剂,及其制备方法和应用 |
JP6480964B2 (ja) * | 2014-03-14 | 2019-03-13 | メタボリック・テクノロジーズ,インコーポレーテッド | 遊離酸形のβ−ヒドロキシ−β−メチル酪酸(HMB)を含有する液体及び食品ならびにその製造法 |
CN109862875A (zh) * | 2016-03-30 | 2019-06-07 | 西姆莱斯股份公司 | 一种活性混合物 |
-
2019
- 2019-06-25 WO PCT/US2019/038948 patent/WO2020263229A1/fr unknown
- 2019-06-25 CN CN201980057166.8A patent/CN113056206A/zh active Pending
- 2019-06-25 AU AU2019453386A patent/AU2019453386A1/en active Pending
- 2019-06-25 CA CA3105039A patent/CA3105039A1/fr active Pending
- 2019-06-25 SG SG11202012984YA patent/SG11202012984YA/en unknown
- 2019-06-25 KR KR1020217010076A patent/KR20220050082A/ko active Search and Examination
- 2019-06-25 JP JP2020572417A patent/JP2022545299A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2019453386A1 (en) | 2021-02-18 |
JP2022545299A (ja) | 2022-10-27 |
KR20220050082A (ko) | 2022-04-22 |
WO2020263229A1 (fr) | 2020-12-30 |
SG11202012984YA (en) | 2021-01-28 |
CN113056206A (zh) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102100091B1 (ko) | 영양 조성물 | |
Kapoor et al. | Coenzyme Q10-a novel molecule | |
JP4850986B2 (ja) | カルノシンあるいはその誘導体および分枝アミノ酸を含む抗酸化活性を有する医薬組成物および/または栄養組成物 | |
US20070292493A1 (en) | Pharmaceutical composition and method for the transdermal delivery of calcium | |
US20070212448A1 (en) | Total enteral nutritious composition | |
WO2007145239A1 (fr) | Agent anti-fatigue contenant une composition d'acides aminés | |
ZA200600203B (en) | Multivitamin syrup for children or young adults | |
US10925845B2 (en) | Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB) | |
US20150216779A1 (en) | Compositions for targeted anti-aging therapy | |
US20050064014A1 (en) | Use of cystathionine | |
US20070293572A1 (en) | Anti-Fatigue Composition | |
US11490644B2 (en) | Co-Q10, krill oil and vitamin D | |
CN115279209A (zh) | 辅酶q产生促进剂和辅酶q产生促进方法 | |
US20220040205A1 (en) | Stability of vitamin d in beta-hydroxy- beta-methylbutyrate (hmb) | |
CA3105039A1 (fr) | Stabilite de la vitamine d dans .beta.-hydroxy .beta.-methylbutyrate (hmb) | |
EP3836803A1 (fr) | Stabilité de la vitamine d dans du beta-hydroxy-beta-méthylbutyrate (hmb) | |
EP4110086A2 (fr) | Compositions nutritionnelles pour favoriser l'entretien de la santé pédiatrique | |
US20210393559A1 (en) | Compositions and Methods of Use of Beta-Hydroxy-Beta-methylbutyrate (HMB) for Improving Muscle Mass, Strength and Muscular Function Without Exercise | |
JP2000302677A (ja) | カルニチン自己産生能改善作用を有する医薬および食品・飼料組成物 |